Insight of oral vaccines as an alternative approach to health and disease management: An innovative intuition and challenges

2021 ◽  
Author(s):  
Nabendu Debnath ◽  
Mony Thakur ◽  
Khushboo ◽  
Neelam Prabha Negi ◽  
Vibhav Gautam ◽  
...  
Keyword(s):  
Disease Management ◽  
Oral Vaccines ◽  
Alternative Approach ◽  
Health And Disease

Chronic disease, women’s health, and “disease management”: the latest trend?

1999 ◽  
Vol 9 (1) ◽  
pp. 18-29 ◽  
Author(s):  
Felicia Gevirtz ◽  
Robert R. Corrato ◽  
Peter Chodoff ◽  
David B. Nash
Keyword(s):  
Chronic Disease ◽  
Disease Management ◽  
Women’S Health ◽  
Women's Health ◽  
Health And Disease

Health and Disease Management Within an Academic Health System

2000 ◽  
Vol 7 (1) ◽  
pp. 21-37 ◽  
Author(s):  
David B. Bernard ◽  
Kenneth D. Coburn ◽  
Mark A. Miani
Keyword(s):  
Disease Management ◽  
Health System ◽  
Academic Health ◽  
Health And Disease

Adolescents with chronic disease and use of technology for receipt of information regarding health and disease management

2014 ◽  
Vol 4 (3) ◽  
pp. 253-259 ◽  
Author(s):  
Catherine Lacey ◽  
Stanford Chun ◽  
Laura Terrones ◽  
Jeannie S. Huang
Keyword(s):  
Chronic Disease ◽  
Disease Management ◽  
Use Of Technology ◽  
Health And Disease

scholarly journals Vaccines, Repurposed Drugs and Alternative Biomedicines for the Management and Prevention of COVID-19

2021 ◽  
Author(s):  
Jeyalakshmi Kandhavelu ◽  
Ramesh Veeriah ◽  
Kumar Subramanian ◽  
Priyatharsini Rajendran ◽  
Olli Yli-Harja ◽  
...  
Keyword(s):  
Disease Management ◽  
Severe Acute Respiratory Syndrome ◽  
Developmental Stage ◽  
Value Added ◽  
Modern Medicine ◽  
Clinical Validation ◽  
Cold Sore ◽  
Alternative Approach ◽  
Repurposed Drugs ◽  
Value Added Products

The Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) popularly called as COVID-19, is a pandemic having affected >200 countries. Globally, quarantine measures have been implemented to slow down the spread of the virus. Yet, the available vaccines and drugs for treating COVID-19 are still in design and developmental stage, requiring clinical validation. This review is focused on the progress in the development of medicines against SARS-CoV-2. As an alternative approach, both conventional and traditional biomedicines are also reported to be in practice, to treat the SARS-CoV-2 infected patients. Considering the therapeutic values of the folk medicines, this review focuses on the usage of high value added products from plants, against COVID-19 in managing the symptoms like fever, cough, cold, sore throat, respiratory disorders and kidney dysfunctions enlisting a few used since time immemorial. It is ardently hoped that scientific intervention of such traditional plants can be integrated to harmonise with modern medicine, to ensure its dosage and safety in augmenting disease management.

scholarly journals The Implementation Chasm Hindering Genome-informed Health Care

2020 ◽  
Vol 48 (1) ◽  
pp. 119-125
Author(s):  
Kevin B. Johnson ◽  
Ellen Wright Clayton ◽  
Justin Starren ◽  
Josh Peterson
Keyword(s):  
Health Care ◽  
Clinical Practice ◽  
Disease Management ◽  
High Quality ◽  
Healthcare Settings ◽  
Care Processes ◽  
Last Mile ◽  
New Knowledge ◽  
Health And Disease ◽  
The Impact

The promises of precision medicine are often heralded in the medical and lay literature, but routine integration of genomics in clinical practice is still limited. While the “last mile” infrastructure to bring genomics to the bedside has been demonstrated in some healthcare settings, a number of challenges remain — both in the receptivity of today's health system and in its technical and educational readiness to respond to this evolution in care. To improve the impact of genomics on health and disease management, we will need to integrate both new knowledge and new care processes into existing workflows. This change will be onerous and time-consuming, but hopefully valuable to the provision of high quality, economically feasible care worldwide.

Patients' attitudes toward their health literacy and the use of digital apps in health and disease management

2021 ◽  
Vol 30 (21) ◽  
pp. 1242-1249
Author(s):  
Michael Klösch ◽  
Firuzan Sari-Kundt ◽  
Christine Reibnitz ◽  
Jürgen Osterbrink
Keyword(s):  
Health Literacy ◽  
Disease Management ◽  
Personal Experience ◽  
Qualitative Data ◽  
Qualitative Content Analysis ◽  
Sensitive Data ◽  
Detailed Understanding ◽  
Attitudes And Perceptions ◽  
Health And Disease ◽  
Research Questions

Background: No qualitative studies have so far been conducted about patients' attitudes and perceptions toward their own health literacy and the use of digital apps in health and disease management based in Austria. Aim: In the context of digital apps, what are patients' attitudes and perceptions with regard to their own health literacy? Method: Guided interviews were conducted with patients in an Austrian hospital to obtain qualitative data. Qualitative content analysis was used to analyse the data. Findings: Responses to the research questions fell into three main categories: ‘health’, ‘health literacy’ and ‘digital applications in health and disease management’, with each having its own set of subcategories. Digital apps appear to be an important strategy for helping patients optimise their own health literacy, as well as their health or disease management. Challenges referred to the handling of sensitive data or the possibility of publishing unfiltered information. Conclusion: Further studies need to be carried out to gain a more detailed understanding of the findings. Personal experience plays an important role in supporting quantitative findings.

Sign in / Sign up

Export Citation Format

Share Document